Formic acid ester coumarin compounds, their preparation methods and uses, and photoinitiator compositions containing them.
By preparing 3-formyl ester coumarin compounds as photoinitiators, the problem of insufficient ultraviolet absorption wavelength of cationic photoinitiators under UV-VIS LED light sources was solved, achieving safe and efficient photocuring effects, which are suitable for various photocuring systems and food packaging.
Patent Information
- Application Number
- CN202410024401.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-08
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2044-01-08
AI Technical Summary
Existing cationic photoinitiators have short UV absorption wavelengths under UV-Vis LED light sources, which limits their application range. Furthermore, traditional anthraquinone photosensitizers have certain reproductive toxicity. Therefore, there is an urgent need to develop safe and effective photoinitiators suitable for UV-VIS LED light sources.
3-Formylcarbamate coumarin compounds were developed as photoinitiators, capable of initiating free radical or cationic photopolymerization reactions under UV-VIS LED light sources. These compounds were prepared via Knauvengel condensation, oxidation, and esterification reactions, and then combined with other compounds to form photoinitiator compositions.
It achieves rapid initiation of polymerization reaction under UV-VIS LED light source, has excellent sensitization performance and safety, is suitable for a variety of photocuring systems, and is suitable for food packaging and other fields.
Smart Images

Figure CN117865922B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of photocuring technology and relates to 3-formyl coumarin compounds suitable for curing UV-VIS LED light sources. This invention also relates to the preparation and uses of 3-formyl coumarin compounds, photoinitiator compositions comprising the same, photocurable compositions, curable materials obtainable from the photocurable compositions, and methods for preparing photocurable materials. Background Technology
[0002] Photoinitiators, also known as photosensitizers or photocuring agents, are compounds that absorb energy of a certain wavelength in the ultraviolet (250-400nm) or visible (400-600nm) light region, generating free radicals, cations, etc., thereby initiating monomer polymerization, cross-linking, and curing. As an important component of photocuring systems, although photoinitiators are present in low concentrations, they are crucial components that determine the photocuring rate and must meet the needs of different photocuring conditions and applications. They determine whether the formulation system can rapidly cross-link and cure under light irradiation, thus transforming from a liquid to a solid state. Furthermore, with the widespread application of photocuring technology in traditional fields such as coatings, inks, microelectronics, and printing, as well as in emerging fields such as the fabrication of laser recording and 3D components, and with the continuous development of UV-VIS LED light source curing technology, it is necessary to develop photoinitiators suitable for UV-VIS LED light sources to meet the diverse application requirements of UV-VIS LED light source curing technology.
[0003] Furthermore, cationic photoinitiators induce cationic photocuring reactions with advantages such as antioxidant inhibition, low shrinkage, good adhesion and chemical resistance, and relatively thorough curing. Therefore, cationic photocuring technology is widely used in electronic products, metal decoration, adhesives, inks, and other fields. Ononium salts, especially thioonium and iodonium salts, are important photoacid generators and are widely used in cationic photocuring. However, the short ultraviolet absorption slope of these substances limits their application under long-wavelength ultraviolet-visible LED light sources. Photosensitizers are typically used to expand their application range, but photoinitiators that can sensitize thioonium salts are few. Currently reported photoinitiators are mostly anthraquinones, which have a polybenzene ring structure and exhibit certain reproductive toxicity. There is an urgent need to develop suitable photoinitiators. Summary of the Invention
[0004] One object of the present invention is to provide a 3-formyl coumarin compound of formula (I) that can be used as a photoinitiator, such as a cleavage-type photoinitiator or a hydrogen-abstraction-type photoinitiator, to initiate free radical photopolymerization, or as a photoinitiator to sensitize onium salt photoinitiators to initiate cationic photopolymerization. The absorption wavelength of the compound of the present invention is suitable for UV-VIS LED light source radiation curing.
[0005] Another object of the present invention is to provide a method for preparing the 3-formylcarbamate coumarin compound of formula (I) of the present invention.
[0006] Another object of the present invention is to provide the use of the 3-formyl coumarin compound of formula (I) of the present invention as a photoinitiator.
[0007] Another object of the present invention is to provide a photoinitiator composition comprising a 3-formyl coumarin compound of formula (I) of the present invention.
[0008] Another object of the present invention is to provide a photocurable composition comprising a 3-formyl coumarin compound of formula (I) of the present invention or a photoinitiator composition of the present invention.
[0009] Another object of the present invention is to provide a curable material that can be obtained from the photocurable composition of the present invention.
[0010] Another object of the present invention is to provide a method for preparing photocurable materials.
[0011] The technical solution for achieving the above-mentioned objectives of this invention can be summarized as follows:
[0012] 1. 3-Formylcarbamate coumarin compounds of formula (I):
[0013]
[0014] in:
[0015] R1 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0016] R2 is H, halogen, nitro, straight-chain or branched C1-C. 16Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0017] R3 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0018] R4 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0019] R5 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0020] and
[0021] R6 is a straight-chain or branched C1-C. 16 alkyl;
[0022] or
[0023] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 3, 4, 5, 6, or 7 partially unsaturated or aromatic carbocyclic or heterocyclic ring fused with the benzene ring in the coumarin structure, wherein the carbocyclic or heterocyclic ring is not substituted or contains one or more substituents independently selected from the group consisting of halogens, C1-C6 alkyl groups, and C1-C6 alkoxy(thio) groups, and the heterocyclic ring contains one or two heteroatoms selected from N, O, and S as ring members;
[0024] or
[0025] R1, R2, and R3, or R2, R3, and R4 together with the carbon atoms they are bonded to form a 6, 7, 8, 9, or 10 partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is not substituted or contains one or more substituents independently selected from the group consisting of halogens, C1-C6 alkyl groups, and C1-C6 alkoxy(sulfo) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0026] 2. A 3-formyl coumarin compound of formula (I) according to item 1, wherein:
[0027] R1 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0028] R2 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0029] R3 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl; and
[0030] R4 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0031] R5 is H or a linear or branched C1-C. 16 Alkyl; and
[0032] R6 is a straight-chain or branched C1-C. 16 alkyl;
[0033] or
[0034] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 5, 6, or 7 partially unsaturated or aromatic carbocyclic or heterocyclic ring fused to the benzene ring in the coumarin structure, wherein the carbocyclic or heterocyclic ring is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the heterocyclic ring contains one or two heteroatoms selected from N, O, and S as ring members;
[0035] or
[0036] R1, R2, and R3, or R2, R3, and R4 together with the carbon atoms they are bonded to form an 8, 9, or 10-member partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0037] 3. A 3-formyl coumarin compound of formula (I) according to item 1 or 2, wherein:
[0038] R1 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups;
[0039] R2 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups that are not substituted or are substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0040] R3 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups;
[0041] R4 is H, nitro, straight-chain, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups;
[0042] R5 is H or a linear or branched C1-C. 16 Alkyl; and
[0043] R6 is a straight-chain or branched C1-C. 16 alkyl;
[0044] or
[0045] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 5, 6, or 7 partially unsaturated or aromatic carbocyclic or heterocyclic ring fused to the benzene ring in the coumarin structure, wherein the carbocyclic or heterocyclic ring is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the heterocyclic ring contains one or two heteroatoms selected from N, O, and S as ring members;
[0046] or
[0047] R1, R2, and R3, or R2, R3, and R4 (preferably R1, R2, and R3), together with the carbon atoms they are bonded to, form an 8, 9, or 10-member partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0048] 4. A 3-formyl coumarin compound of formula (I) according to any one of 1-3, wherein: R1 is H, nitro, straight-chain or branched C1-C 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl, or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups;
[0049] R2 is H, nitro, straight-chain, or branched C1-C. 12Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, mono- or di-C1-C4 alkylamino or C1-C 12 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0050] R3 is H, nitro, straight-chain, or branched C1-C. 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups;
[0051] R4 is H, nitro, straight-chain, or branched C1-C. 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups;
[0052] R5 is H or a linear or branched C1-C. 12 Alkyl; and
[0053] R6 is a straight-chain or branched C1-C. 12 alkyl;
[0054] or
[0055] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 5, 6, or 7 partially unsaturated or aromatic carbocyclic or heterocyclic ring fused to the benzene ring in the coumarin structure, wherein the carbocyclic or heterocyclic ring is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the heterocyclic ring contains one or two heteroatoms selected from N, O, and S as ring members;
[0056] or
[0057] R1, R2, and R3, or R2, R3, and R4 together with the carbon atoms they are bonded to form an 8, 9, or 10-member partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0058] 5. A 3-formyl coumarin compound of formula (I) according to any one of items 1-4, wherein: R1 is H, a straight-chain or branched C1-C 12 Alkyl or C1-C 16 Alkoxy(sulfide) group;
[0059] R2 is H, linear or branched C1-C 12 Alkyl, C2-C6 ynyl, diC1-C4 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the C2-C6 alkynyl group is replaced by a diC1-C4 alkylamino group. 10 Aryl substitution;
[0060] R3 is H, nitro, straight-chain, or branched C1-C. 12 Alkyl or C1-C 16 Alkoxy(sulfide) group;
[0061] R4 is H, linear, or branched C1-C. 12 Alkyl or C1-C 16 Alkoxy(sulfide) group;
[0062] R5 is H; and
[0063] R6 is a straight-chain or branched C1-C6 alkyl group;
[0064] or
[0065] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 6-membered aromatic carbon ring fused with the benzene ring in the coumarin structure.
[0066] or
[0067] R1, R2, and R3, or R2, R3, and R4 together with their bonded carbon atoms form an 8, 9, or 10-member partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is unsubstituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl groups, the biheterocycle containing one N heteroatom as a ring member, preferably the N heteroatom being a shared atom of the biheterocycle; more preferably the biheterocycle has a dihydroisoquinolinedione structure or the structure of formula (a):
[0068]
[0069] in
[0070] * indicates the position where the coumarin structure is fused with the benzene ring; and
[0071] The dihydroisoquinolinedione structure and the structure shown in formula (a) are not substituted or contain one or more C1-C6 alkyl groups as substituents. Preferably, the cyclic nitrogen atom on the dihydroisoquinolinedione structure is substituted by a C1-C6 alkyl group and the structure shown in formula (a) is not substituted or contains one or more C1-C6 alkyl groups as substituents.
[0072] 6. A 3-formyl ester coumarin compound of formula (I) according to any one of items 1-5, wherein at least one of R1, R2, R3 and R4 is not H and R5 is H, or preferably two or three of R1, R2, R3 and R4 are H and R5 is H.
[0073] 7. A 3-formyl coumarin compound of formula (I) according to any one of claims 1-5, wherein the 3-formyl coumarin compound of formula (I) is selected from the group consisting of:
[0074]
[0075]
[0076] 8. A method for preparing a 3-formyl coumarin compound of formula (I) as described in any one of claims 1-7, comprising the following steps:
[0077] (1) Knoevenagel condensation reaction: Compound (II) is subjected to a Knoevenagel condensation reaction with a C1-C6 alkyl ester of acetoacetic acid to obtain compound (III):
[0078]
[0079] (2) Oxidation reaction: Compound (III) is oxidized with an oxidizing agent to obtain compound (IV).
[0080]
[0081] (3) Esterification reaction: The compound of formula (IV) is esterified with alcohol R6-OH to obtain the compound of formula (I).
[0082]
[0083] In the above formulas, R1, R2, R3, R4, R5 and R6 are defined as in any of the terms 1-7.
[0084] 9. According to the method in item 8, where:
[0085] The Knauvengay condensation reaction in step (1) is carried out in the presence of one or more catalysts selected from the group consisting of: amines such as primary amines, secondary amines, tertiary amines and their corresponding ammonium salts, preferably piperidine; inorganic bases such as alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal carbonates and alkali metal or alkaline earth metal bicarbonates; inorganic salts such as potassium fluoride, aluminum phosphate, diammonium hydrogen phosphate; Lewis acid and tertiary amine conjugates such as TiCl4 / piperidine or TiCl4 / triethylamine.
[0086] 10. The method according to item 8 or 9, wherein in the Knauvengel condensation reaction in step (1), the molar ratio of the compound of formula (II) to the C1-C6 alkyl ester of acetoacetic acid is 1:0.1-1:10, preferably 1:0.3-1:5, more preferably 1:0.9-1:3.
[0087] 11. The method according to any one of items 8-10, wherein in the oxidation reaction of step (2), the molar ratio of compound (III) to oxidant is 1:1-1:5, preferably 1:1.5-1:3.
[0088] 12. The method according to any one of items 8-11, wherein the oxidant in step (2) is selected from selenium dioxide and acidic peroxides, such as acidic hydrogen peroxide and acidic alkali metal peroxides.
[0089] 13. Use of the 3-formyl coumarin compound of formula (I) as any one of items 1-7 as a photoinitiator.
[0090] 14. According to the use of item 13, the 3-formyl coumarin compound of formula (I) is used as a pyrolysis photoinitiator in a UV-VISLED light source curing system, particularly in a light source curing system with a radiation wavelength of 300-550 nm, especially 365-475 nm.
[0091] 15. According to the use of item 13, the 3-formyl coumarin compound of formula (I) is used as a hydrogen-abstracting photoinitiator in a UV-VISLED light source curing system, particularly in a light source curing system with a radiation wavelength of 300-550 nm, especially 365-475 nm.
[0092] 16. According to the use of item 15, wherein the 3-formyl ester coumarin compound of formula (I) is used in combination with a compound selected from tertiary amine compounds, α-amino acid compounds or thiols.
[0093] 17. Use of the 3-formyl coumarin compound of formula (I) as a photoinitiator sensitized onium salt as described in any one of items 1-7, particularly as a photoinitiator sensitized onium salt in UV-VIS LED light source curing systems, especially as a photoinitiator sensitized onium salt in light source curing systems with radiation wavelengths of 300-550 nm, particularly 365-475 nm.
[0094] 18. According to the use of item 17, the onium salt is selected from iodonium salts and thiodonium salts, preferably from diaryliodonium salts and triarylthiodonium salts.
[0095] 19. According to the use of item 17 or 18, wherein the onium salt sensitized with the 3-formyl coumarin compound of formula (I) is used to initiate a free radical photopolymerization reaction, or to initiate a cationic photopolymerization reaction, or to initiate a free radical-cationic hybrid photopolymerization reaction.
[0096] 20. A photoinitiator composition comprising a 3-formyl coumarin compound of formula (I) according to any one of claims 1-7.
[0097] 21. The photoinitiator composition according to claim 20, wherein the composition comprises a 3-formyl coumarin compound of formula (I) and a compound selected from tertiary amine compounds, α-amino acid compounds or thiols.
[0098] 22. The photoinitiator composition according to claim 20, wherein the photoinitiator composition comprises a 3-formyl ester coumarin compound of formula (I) and an onium salt, preferably selected from iodonium salts and thiodonium salts, more preferably selected from diaryliodonium salts and triarylthiodonium salts.
[0099] 23. A photocurable composition comprising at least one 3-formyl coumarin compound of formula (I) as described in any one of claims 1-7 or a photoinitiator composition as described in any one of claims 20-22.
[0100] 24. A cured material that can be obtained from the photocurable composition described in item 23.
[0101] 25. A method for preparing a photocurable material, comprising irradiating the photocurable composition of claim 23 with a light source having a radiation wavelength of 300-550 nm, particularly 365-475 nm, such as a UV-VIS LED light source.
[0102] The 3-formyl coumarin compound of formula (I) of this invention comprises both a coumarin group and a 3-formyl coumarin group. This compound exhibits good photosensitivity in the 300-550 nm range, particularly 365-475 nm. Upon absorbing light energy, it rapidly undergoes cleavage to generate active free radicals, continuously initiating polymerization. It can also rapidly (e.g., within seconds) initiate the polymerization of polymerizable monomers, completing the polymerization reaction within a short time (e.g., 10 minutes, especially 3 minutes). The 3-formyl coumarin compound of formula (I) of this invention also possesses excellent sensitization properties, capable of transferring energy to other co-initiators, such as hydrogen donors or onium salts, after absorbing light energy, initiating free radical polymerization or cationic polymerization. The 3-formyl coumarin compound of formula (I) of this invention can initiate deep curing of monomers (acrylate compounds) even at low concentrations (e.g., 0.01% by mass). Therefore, it has significant advantages in photosensitivity and is suitable as a photoinitiator for curing UV-VIS LED light sources. The compound of formula (I) of this invention is safe and non-toxic, and compared with traditional photoinitiators, it reduces the harm to humans and the environment, and can also be used in food packaging and other fields. Attached image description:
[0103] Figure 1 The UV-Vis absorption spectra of the 3-formyl coumarin compounds in acetonitrile for Examples 1-3 are shown.
[0104] Figure 2 The graphs show the monomer conversion versus exposure time curves for the free radical photopolymerization of acrylate monomers initiated by the 3-formyl coumarin compounds of Examples 1-3 as photoinitiators; wherein (a) TPGDA polymerization is initiated by the photoinitiator (1% w / w) under different light sources; and (b) the photoinitiator / EDB (1% / 1.16% w / w) at 415 nm and 50 mW / cm. 2 TPGDA polymerization is induced under light source;
[0105] Figure 3 The curves represent the corresponding events in the ring-opening polymerization of epoxy monomer 6110 initiated by the sensitized iodine or thionium salts of the 3-formyl coumarin compound of this invention. (a) shows the relationship between monomer conversion rate and exposure time, and the relationship between heat flux and exposure time under different light sources, using the compound / iodine salt GR54 (0.2% / 4% w / w) from Example 2. (b) shows the relationship between monomer conversion rate and exposure time, using the compound / GR54 (0.2% / 4% w / w) from Example 1 or 3, or GR54 only. Light source: 385nm LED, light intensity: 100mW / cm². 2LED, (c) is the relationship curve between monomer conversion rate and exposure time, wherein the compound of Examples 1-3 / GR-SS061 (0.2% / 4% w / w) or GR-SS061 only is used, and the light source is 415nm, 100mW / cm 2 .
[0106] Figure 4 Photographs showing the deep curing initiated by the 3-formyl coumarin compounds of Examples 1 and 2; wherein (a) is the length of deep curing of TPGDA initiated by the 3-formyl coumarin compound of Example 1 (0.01 wt%); and (b) is the length of deep curing of TPGDA initiated by the 3-formyl coumarin compound of Example 2 (0.01 wt%). The light source was a 415 nm LED at 100 mW / cm². 2 Exposure time: 5 minutes. Detailed Implementation
[0107] 3-Formylcarbamate coumarin compounds of formula (I):
[0108] One aspect of the present invention relates to 3-formylcarbamate coumarin compounds of formula (I):
[0109]
[0110] in:
[0111] R1 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0112] R2 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0113] R3 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0114] R4 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R mC6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0115] R5 is H, halogen, nitro, straight-chain or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 alkynyl group, C6-C 10 aryl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H, halogen, and nitro is unsubstituted or contains one or more substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy(thio) group, and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0116] and
[0117] R6 is a straight-chain or branched C1-C. 16 alkyl;
[0118] or
[0119] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 3, 4, 5, 6, or 7 partially unsaturated or aromatic carbocyclic or heterocyclic ring fused with the benzene ring in the coumarin structure, wherein the carbocyclic or heterocyclic ring is not substituted or contains one or more substituents independently selected from the group consisting of halogens, C1-C6 alkyl groups, and C1-C6 alkoxy(thio) groups, and the heterocyclic ring contains one or two heteroatoms selected from N, O, and S as ring members;
[0120] or
[0121] R1, R2, and R3, or R2, R3, and R4 together with the carbon atoms they are bonded to form a 6, 7, 8, 9, or 10 partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is not substituted or contains one or more substituents independently selected from the group consisting of halogens, C1-C6 alkyl groups, and C1-C6 alkoxy(sulfo) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0122] In this invention, the prefix "C" n -Cm "In each case, it indicates that the group contains nm of carbon atoms."
[0123] "Halogen" refers to fluorine, chlorine, bromine, and iodine. In this invention, halogens are preferably fluorine, chlorine, bromine, or combinations thereof.
[0124] The term "C" used in this article n -C m "Alkyl" refers to a straight-chain or branched saturated hydrocarbon group having 1-16, 1-12, 1-8, 1-4, or 2, 4, 6, 8, 10, 12, or 14 carbon atoms, such as methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, n-hexyl, 1-methylpentyl 2-Methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-dodecyl and n-hexadecyl and their isomers, etc.
[0125] The term "C6-C" is used in this article. m "Aryl" refers to a monocyclic or bicyclic aromatic hydrocarbon group containing 6-m carbon atoms, such as 6-10 carbon atoms, including phenyl, tolyl, ethylphenyl, propanylphenyl, butylphenyl, xylyl, methylethylphenyl, diethylphenyl, methylpropylphenyl, naphthyl and its isomers.
[0126] The term "C3-C" is used in this article. m "Cycloalkyl" refers to a saturated alicyclic monocyclic group having 3-m ring carbon atoms, such as 3-10, 3-8, 3-7, 4-8, 4-7, 5-8, 5-7 or 4, 5, 6, 7, 8 or 9 ring carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodecyl and their isomers.
[0127] The term "C3-C" m cycloalkyl-C n -C m "alkyl" indicates that it is formed by C3-C m Cycloalkyl-substituted C n -C m Alkyl groups, where the two m's can be the same or different, and C' ... n -Cm Alkyl and C3-C m Cycloalkyl groups are defined as used herein. C3-C m cycloalkyl-C n -C m Alkyl groups can be C3-C6 cycloalkyl or C1-C4 alkyl groups, such as cyclopropylmethyl, cyclopropylethyl, cyclopropylpropyl, cyclopropylbutyl, cyclobutylmethyl, cyclobutylethyl, cyclobutylpropyl, cyclobutylbutyl, cyclopentylmethyl, cyclopentylethyl, cyclopentylpropyl, cyclopentylbutyl, cyclohexylmethyl, cyclohexylethyl, cyclohexylpropyl, cyclohexylbutyl and their isomers, etc.
[0128] The term "C" used in this article n -C m "Alkoxy(sulfo) group" includes "C n -C m "alkoxy" and "C" n -C m "Alkylthio" refers to a group with a C-position of 10 ... n -C m alkyl corresponding to open chain C n -C m In alkanes, any carbon atom is bonded with either an oxygen atom or a sulfur atom as a linking group. n -C m Alkyl group. C n -C m C in alkoxy (sulfur) group n -C m Alkyl groups are defined as used herein. C1-C6 alkoxy(thio) groups include, for example, methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, 2-butoxy, tert-butoxy, pentoxy, isopentoxy, hexoxy, and their isomers. C1-C8 alkoxythio groups can be methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, 2-butylthio, tert-butylthio, pentoxy, isopentoxy, hexylthio, and their isomers.
[0129] The term "single or double C" is used in this article. n -C m "alkylamino" refers to an amino group consisting of one or two carbon atoms. n -C m Alkyl-substituted amino groups, wherein C n -C m Alkyl groups are defined as used herein.
[0130] As used herein, the term biheterocycle includes two mutually fused rings, at least one of which is a heterocycle, wherein the biheterocycle contains one or two N, O, or S heteroatoms as ring members. Examples of biheterocycles are isoquinolines, dihydroisoquinolines, or dihydroisoquinolinediones, and the structure of formula (a) as defined herein.
[0131] In one embodiment, R1 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl.
[0132] In one embodiment, R1 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0133] In one embodiment, R1 is H, nitro, linear, or branched C1-C. 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl, or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0134] In one implementation, R1 is H, a linear or branched C1-C 12 Alkyl or C1-C 16 Alkoxy(thio) group. In one embodiment, R1 is H, a straight-chain or branched C1-C6 alkyl group, or a C1-C6 alkyl group. 14 Alkoxy(sulfur) group.
[0135] In one embodiment, R2 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl.
[0136] In one embodiment, R2 is H, nitro, linear, or branched C1-C. 14 Alkyl, C3-C7 cycloalkyl, C3-C7 cycloalkyl-C1-C 14 Alkyl, C2-C8 alkenyl, C2-C8 alkynyl, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl.
[0137] In one embodiment, R2 is H, nitro, linear, or branched C1-C. 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl, C2-C6 alkenyl, C2-C6 alkynyl, mono- or di-C1-C4 alkylamino or C1-C 12 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl;
[0138] In one implementation, R2 is H, a linear or branched C1-C 12 Alkyl, C2-C6 ynyl, mono- or di-C1-C4 alkylamino or C1-C16 Alkoxy(thio) group; wherein the C2-C6 alkynyl group is replaced by a single or two C1-C4 alkylamino group. 10 Aryl substitution.
[0139] In one embodiment, R2 is H, a straight-chain or branched C1-C6 alkyl, C2-C4 alkynyl, mono- or di-C1-C4 alkylamino, or C1-C 14 Alkoxy(thio) group; wherein the C2-C4 alkynyl group is substituted with a phenyl group that is mono- or di-C1-C4 alkylamino group. In one embodiment, R2 is H, a straight-chain or branched C1-C6 alkyl, C2-C4 alkynyl, di-C1-C4 alkylamino, or C1-C6 alkyl. 14 Alkoxy(thio) group; wherein the C2-C4 alkynyl group is replaced by a phenyl group that is substituted with a diC1-C4 alkylamino group.
[0140] In one embodiment, R3 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl.
[0141] In one embodiment, R3 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0142] In one embodiment, R3 is H, nitro, linear, or branched C1-C. 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl or C1-C16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0143] In one embodiment, R3 is H, nitro, linear, or branched C1-C. 12 Alkyl or C1-C 16 Alkoxy(sulfur) group. In one embodiment, R3 is H, nitro, straight-chain or branched C1-C6 alkyl or C1-C6 alkoxy(sulfur) group.
[0144] In one embodiment, R4 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl, C2-C 10 alkenyl, C2-C 10 Alkyne, mono- or di-C1-C6 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the aforementioned groups other than H and nitro are not substituted or contain one or more substituents independently selected from the group consisting of: C1-C6 alkyl, C1-C6 alkoxy(thio) group and R. m ;where R m C6-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups that are unsubstituted or substituted with one or more C1-C6 alkyl groups, C1-C6 alkoxy (sulfur) groups, and mono- or di-C1-C6 alkylamino groups. 10 Aryl.
[0145] In one embodiment, R4 is H, nitro, linear, or branched C1-C. 16 Alkyl, C3-C 10 cycloalkyl, C3-C 10 cycloalkyl-C1-C 16 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0146] In one embodiment, R4 is H, nitro, linear, or branched C1-C. 12 Alkyl, C5-C7 cycloalkyl, C5-C7 cycloalkyl-C1-C 12 Alkyl or C1-C 16 Alkoxy(thio) group; wherein each of the aforementioned groups other than H and nitro is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0147] In one implementation, R4 is H, a linear or branched C1-C. 12 Alkyl or C1-C 16 Alkoxy (thio) group. In one embodiment, R4 is H, a straight-chain or branched C1-C6 alkyl group, or a C1-C6 alkoxy (thio) group. In one embodiment, R4 is H or a straight-chain or branched C1-C6 alkyl group.
[0148] In one implementation, R5 is H or a linear or branched C1-C. 16 alkyl.
[0149] In one implementation, R5 is H or a linear or branched C1-C. 12 Alkyl group. In one embodiment, R5 is H or a straight-chain or branched C1-C6 alkyl group.
[0150] In one implementation, R5 is H.
[0151] In one implementation, R6 is a linear or branched C1-C 16 alkyl.
[0152] In one implementation, R6 is a linear or branched C1-C 12 alkyl.
[0153] In one embodiment, R6 is a straight-chain or branched C1-C6 alkyl group, such as methyl, ethyl, propyl, butyl, pentyl, or hexyl.
[0154] In one embodiment, R1 and R2, R2 and R3, or R3 and R4 together with their bonded carbon atoms form a 5, 6, or 7 partially unsaturated or aromatic carbocyclic or heterocyclic ring fused to the benzene ring in the coumarin structure, wherein the carbocyclic or heterocyclic ring is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the heterocyclic ring contains one or two heteroatoms selected from N, O, and S as ring members.
[0155] In one embodiment, R1 and R2, R2 and R3, or R3 and R4 together with their bonded carbon atoms form a 5, 6, or 7 partially unsaturated or aromatic carbon ring fused to the benzene ring in the coumarin structure, wherein the carbon ring is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0156] In one embodiment, R1 and R2, R2 and R3, or R3 and R4 together with their bonded carbon atoms form a 6-membered aromatic carbon ring fused with the benzene ring in the coumarin structure, wherein the carbon ring is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups.
[0157] In one embodiment, R1 and R2, R2 and R3, or R3 and R4 together with their bonded carbon atoms form a 6-membered aromatic carbon ring fused with the benzene ring in the coumarin structure, wherein the carbon ring is not substituted or contains one or more C1-C6 alkyl substituted compounds.
[0158] In one embodiment, R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 6-membered aromatic carbon ring (i.e., a benzene ring) fused with the benzene ring in the coumarin structure.
[0159] In one embodiment, R1, R2, and R3, or R2, R3, and R4 together with their bonded carbon atoms form an 8, 9, or 10-member partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is not substituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0160] In one embodiment, R1, R2, and R3, or R2, R3, and R4 (preferably R1, R2, and R3), together with their bonded carbon atoms, form an 8, 9, or 10-member partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is unsubstituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl and C1-C6 alkoxy(thio) groups, and the biheterocycle contains one or two heteroatoms selected from N, O, and S as ring members.
[0161] In one embodiment, R1, R2, and R3, or R2, R3, and R4 (preferably R1, R2, and R3), together with their bonded carbon atoms, form an 8, 9, or 10-member (preferably 8 or 10-member, more preferably 10-member) partially unsaturated or aromatic bicarbonate ring or biheterocycle fused to the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is unsubstituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl groups, the biheterocycle containing one N heteroatom as a ring member, preferably the N heteroatom being a shared atom of the biheterocycle; preferably the biheterocycle has a dihydroisoquinolinedione structure or a structure of formula (a):
[0162]
[0163] in
[0164] * indicates the position where the coumarin structure is fused with the benzene ring; and
[0165] The dihydroisoquinolinedione structure and the structure shown in formula (a) are not substituted or contain one or more C1-C6 alkyl groups as substituents. Preferably, the cyclic nitrogen atom on the dihydroisoquinolinedione structure is substituted by a C1-C6 alkyl group and the structure shown in formula (a) is not substituted or contains one or more (e.g., 1-8, 1-6, or 2-6) C1-C6 alkyl groups as substituents.
[0166] In one implementation scheme
[0167] R1 is H, linear or branched C1-C 12 Alkyl or C1-C 16 Alkoxy(sulfide) group;
[0168] R2 is H, linear or branched C1-C 12 Alkyl, C2-C6 ynyl, diC1-C4 alkylamino or C1-C 16 Alkoxy(thio) group; wherein the C2-C6 alkynyl group is replaced by a diC1-C4 alkylamino group. 10 Aryl substitution;
[0169] R3 is H, nitro, straight-chain, or branched C1-C. 12 Alkyl or C1-C 16 Alkoxy(sulfide) group;
[0170] R4 is H, linear, or branched C1-C. 12 Alkyl or C1-C 16 Alkoxy(sulfide) group;
[0171] R5 is H; and
[0172] R6 is a straight-chain or branched C1-C6 alkyl group;
[0173] or
[0174] R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 6-membered aromatic carbon ring fused with the benzene ring in the coumarin structure.
[0175] or
[0176] R1, R2, and R3, or R2, R3, and R4 (preferably R1, R2, and R3), together with their bonded carbon atoms, form an 8, 9, or 10-member (preferably 8 or 10-member, more preferably 10-member) partially unsaturated or aromatic bicarbonate ring or biheterocycle fused with the benzene ring in the coumarin structure, wherein the bicarbonate ring or biheterocycle is unsubstituted or contains one or more substituents independently selected from the group consisting of C1-C6 alkyl groups, the biheterocycle containing one N heteroatom as a ring member, preferably the N heteroatom being a shared atom of the biheterocycle; preferably the biheterocycle has a dihydroisoquinolinedione structure or a structure of formula (a):
[0177]
[0178] in
[0179] * indicates the position where the coumarin structure is fused with the benzene ring; and
[0180] The dihydroisoquinolinedione structure and the structure shown in formula (a) are not substituted or contain one or more C1-C6 alkyl groups as substituents. Preferably, the cyclic nitrogen atom in the dihydroisoquinolinedione structure is substituted with a C1-C6 alkyl group, and the structure shown in formula (a) is not substituted or contains one or more C1-C6 alkyl groups as substituents.
[0181] Preferably, at least one of R1, R2, R3 and R4 is not H.
[0182] In one embodiment, at least one of R1, R2, R3, and R4 is not H, and R5 is H. In another embodiment, one, two, or three of R1, R2, R3, and R4, preferably two or three, are H, and R5 is H.
[0183] In one embodiment, the nitrogen atom (if present) on the heterocycle or biheterocycle of the present invention does not contain a hydrogen atom.
[0184] In one embodiment, the 3-formyl coumarin compound of formula (I) has the structure shown in formula (I-1):
[0185]
[0186] R4, R5, and R6 are defined as above;
[0187] Rx and Ry are independently selected from C1-C6 alkyl and C1-C6 alkoxy(thio) groups, preferably C1-C6 alkyl, more preferably C1-C4 alkyl; and
[0188] a and b are independent values of 0-6, with 0, 1, 2, 3 or 4 being preferred.
[0189] In the structure shown in equation (I-1), R1, R2 and R3 form the double heterocycle of equation (a).
[0190] In one embodiment, the 3-formyl coumarin compound of formula (I) has the structure shown in formula (I-2):
[0191]
[0192] R4, R5, and R6 are defined as above;
[0193] Rx is a C1-C6 alkyl or C1-C6 alkoxy(thio) group, preferably a C1-C6 alkyl group;
[0194] Rz is a C1-C6 alkyl group; and
[0195] c is 0-3, preferably 0 or 1.
[0196] In the structure shown in formula (I-2), R1, R2 and R3 form a dihydroisoquinoline dione bicyclic ring.
[0197] In one embodiment, the 3-formyl coumarin compound of formula (I) is selected from the group consisting of:
[0198]
[0199]
[0200] Process for the preparation of 3-formylformic acid ester coumarin compounds of formula (I)
[0201] One aspect of the present invention provides a method for preparing the 3-formylcarbamate coumarin compound of formula (I) of the present invention, comprising the following steps:
[0202] (1) Knoevenagel condensation reaction: Compound (II) is subjected to a Knoevenagel condensation reaction with a C1-C6 alkyl ester of acetoacetic acid to obtain compound (III):
[0203]
[0204] (2) Oxidation reaction: Compound (III) is oxidized with an oxidizing agent to obtain compound (IV).
[0205]
[0206] (3) Esterification reaction: The compound of formula (IV) is esterified with alcohol R6-OH to obtain the compound of formula (I).
[0207]
[0208] In the above formulas, R1, R2, R3, R4, R5 and R6 are defined as above.
[0209] According to the present invention, starting from the compound of formula (II), a Knauvengel condensation reaction is first carried out to obtain the 3-acetylcoumarin compound of formula (III), followed by an oxidation reaction and an esterification reaction to prepare the 3-formylcoumarin compound of formula (I).
[0210] Step (1) Knoevenagel condensation reaction
[0211] Compound (II) is subjected to a Knauvengel condensation reaction with a C1-C6 alkyl ester of acetoacetic acid to give compound (III):
[0212]
[0213] R1, R2, R3, R4 and R5 are defined as above.
[0214] According to the present invention, the compound of formula (II) has a benzene ring structure containing adjacent -C(=O)R5 and a hydroxyl group, and can be synthesized into a coumarin ring via a Knauvengel condensation reaction. Specifically, in this reaction, -C(=O)R5 preferably undergoes condensation with a C1-C6 alkyl ester of acetoacetic acid under the action of a catalyst, dehydrating to form a carbon-carbon double bond, and the hydroxyl group undergoes an exchange reaction with the ester bond of the C1-C6 alkyl ester of acetoacetic acid, removing the corresponding alcohol to form a new ester bond, thereby forming a coumarin ring, thus obtaining the compound of formula (III).
[0215] To accelerate the Knauvengay condensation reaction, the above reaction is usually carried out in the presence of a catalyst suitable for the Knauvengay condensation reaction. As catalysts, amines such as primary, secondary, and tertiary amines and their corresponding ammonium salts are commonly used, preferably piperidine; inorganic bases such as alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal carbonates, and alkali metal or alkaline earth metal bicarbonates; inorganic salts such as potassium fluoride, aluminum phosphate, and diammonium hydrogen phosphate; and Lewis acid and tertiary amine complexes such as TiCl4 / piperidine or TiCl4 / triethylamine. The amount of catalyst used, based on the compound of formula (II), can be 1-20% by weight, or 2-15% by weight, or 3-15% by weight.
[0216] The above-described Knauvengael condensation reaction is typically carried out in a solvent, preferably an organic solvent, and more preferably a protic solvent. There are no particular restrictions on the type of solvent, as long as it can dissolve the compound of formula (II) with the C1-C6 alkyl acetoacetic acid and is chemically inert to the Knauvengael condensation reaction, i.e., it does not participate in the reaction. Suitable solvents include, for example, alcohols (such as ethanol), ethers (such as diethyl ether), ketones (such as acetone), aromatic hydrocarbons (such as toluene), dimethyl sulfoxide, or N,N-dimethylformamide, with alcohols such as ethanol being preferred.
[0217] An example of a C1-C6 alkyl acetoacetate is ethyl acetoacetate.
[0218] The molar ratio of the compound of formula (II) to the C1-C6 alkyl ester of acetoacetic acid is 1:0.1-1:10 (e.g., 1:0.2, 1:0.3, 1:0.8, 1:0.9, 1:1, 1:1.1, 1:1.2, 1:1.5, 1:1.8, 1:2, 1:3, 1:4, 1:5 or 1:8), preferably 1:0.3-1:5, more preferably 1:0.9-1:3 or 1:1.1-1:3.
[0219] The temperature range for the Knauvengel condensation reaction is typically 40-120°C, preferably 60-90°C. There are no particular limitations on the reaction time, which is usually 2-20 hours or 3-15 hours, preferably 3-10 hours or 3-6 hours.
[0220] After the Knauvengel condensation reaction is completed, the crude product of compound (III) is obtained. If further purification of compound (III) is desired, the compound can be further purified, for example by recrystallization. The choice of recrystallization solvent is conventional and not particularly limited. According to the invention, it is advantageous to recrystallize the crude product of compound (III) using an alcohol (such as ethanol).
[0221] Step (2) Oxidation reaction
[0222] Compound (III) is oxidized with an oxidizing agent to obtain compound (IV).
[0223]
[0224] R1, R2, R3, R4 and R5 are defined as above.
[0225] The oxidant can be selected from selenium dioxide and acidic peroxides, such as acidic hydrogen peroxide and acidic alkali metal peroxides.
[0226] This oxidation reaction is typically carried out in an organic solvent, preferably a polar organic solvent. Suitable solvents include, for example, pyridine, piperidine, and triethylamine.
[0227] The molar ratio of the compound of formula (III) to the oxidant can be 1:1 to 1:5 (e.g., 1:1.2, 1:1.5, 1:1.8, 1:2, 1:2.5, 1:3 or 1:4), preferably 1:1.5 to 1:3.
[0228] The temperature range for the above oxidation reaction is typically 30-200°C, preferably 40-150°C (e.g., 50°C, 60°C, 80°C, 100°C, 150°C, or 180°C). The oxidation reaction time can be 0.1-10 hours, preferably 0.3-5 hours.
[0229] According to the present invention, the reaction process can be monitored during the oxidation reaction. In one embodiment, the reaction is stopped when impurities are detected during the oxidation reaction. The monitoring can be performed using a spot test tube. After the reaction is complete, the reactants can be treated with hydrochloric acid.
[0230] Step (3) Esterification reaction
[0231] In the esterification of compound (IV), the hydroxyl group in the carboxyl group is converted into an ester group, thereby obtaining compound (I). The esterification reagent used is an alcohol R6-OH, such as methanol.
[0232] To accelerate the esterification reaction, the above-mentioned esterification reaction is usually carried out in the presence of a catalyst suitable for esterification. Both acidic and basic catalysts can be used as catalysts. For example, sulfuric acid, perchloric acid, zinc chloride, ferric chloride, pyridine, p-toluenesulfonic acid, sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, sodium tert-butoxide, sodium ethoxide, sodium hydride, potassium hydride, calcium hydride, tetramethylammonium hydroxide, tertiary amines (e.g., trialkylamines, such as trimethylamine and triethylamine), or any combination thereof can be used. The amount of catalyst used is conventional and can be determined by common knowledge in the art or through several routine preliminary experiments.
[0233] To improve the yield of the 3-formyl ester coumarin compounds of formula (I) of the present invention, it is advantageous to remove the water produced during the esterification reaction. This can be done, for example, by distillation / condensation.
[0234] The esterification reaction described above is typically carried out in a solvent, preferably an organic solvent. There are no particular restrictions on the type of solvent, as long as it can dissolve the compound of formula (IV) and the esterifying agent and is chemically inert to the esterification reaction, i.e., does not participate in the esterification reaction. Examples of solvents include tetrahydrofuran, benzene, toluene, N,N-dimethylformamide, dichloromethane, and acetone. A single solvent or a mixture of two or more solvents can be used.
[0235] There are no particular restrictions on the relative amounts of the compound of formula (IV) and the alcohol R6-OH. Generally, the molar ratio of the two is 1:1.05-1:2.0, preferably 1:1.1-1:1.8, for example 1:1.2.
[0236] Esterification can be carried out over a very wide temperature range. Advantageously, according to the invention, the esterification reaction is carried out at temperatures ranging from 10°C to 150°C (e.g., 20°C, 30°C, 40°C, 50°C, 60°C, 80°C, 100°C, or 120°C), preferably from 20°C to 120°C or from 30°C to 80°C. There are no particular limitations on the esterification reaction time; it is typically carried out for 0.5–24 hours, preferably 0.8–12 hours.
[0237] After the esterification reaction is completed, a reaction mixture containing compound (I) is obtained. Therefore, the reaction mixture needs to be post-treated to obtain a purified compound (I). Generally, the reaction mixture obtained from the esterification reaction is first filtered, and the filtrate is collected. Then, the filtrate is washed to remove the catalyst and unreacted reactants. There are no particular limitations on the washing solution, as long as it can remove the catalyst and unreacted reactants. Examples of washing solutions include dilute hydrochloric acid (aqueous solution), saturated sodium bicarbonate aqueous solution, and water. There are no particular limitations on the concentration of the dilute hydrochloric acid; generally, a concentration of 5-12% is used. Washing with the washing solution can be performed once or multiple times; in the case of multiple washes, a single washing solution can be used, or different washing solutions can be used sequentially. According to an advantage of the invention, the filtrate obtained from filtering the reaction mixture from the esterification reaction is washed sequentially with dilute hydrochloric acid, saturated sodium bicarbonate aqueous solution, and water. Of course, after each washing with the washing solution, the aqueous phase needs to be discarded before washing the organic phase with the next washing solution. After washing, drying is required to remove residual water. For this purpose, anhydrous sodium sulfate is typically used for drying. After drying, the residual organic solvent is removed. There are no particular limitations on the method used to remove the organic solvent; it is usually removed by vacuum distillation. After removing the residual organic solvent, the crude product of formula (I) is obtained. If it is desired to further improve the purity of the compound (I), the compound can be further purified, for example, by recrystallization. The choice of recrystallization solvent is conventional and there are no particular limitations. According to the invention, it is advantageous to recrystallize the crude product of formula (I) using petroleum ether, methanol, ethanol, or a mixture thereof.
[0238] The 3-formyl coumarin compound of formula (I) of this invention exhibits strong absorption in the wavelength range of 300-550 nm, particularly in the 365-475 nm range. Therefore, it can be used as a photoinitiator in UV-VIS LED light source curing systems, especially suitable for long-wavelength UV-VIS LED light source curing. Moreover, the compound of formula (I) of this invention is safe and non-toxic, and compared with traditional photoinitiators, it has reduced harm to human health and the environment, and can also be used in food packaging and other fields.
[0239] Use of the compounds of this invention as photoinitiators
[0240] One aspect of the present invention provides the use of the 3-formyl coumarin compound of formula (I) of the present invention as a photoinitiator, such as a cleavage-type photoinitiator or a hydrogen-abstracting photoinitiator.
[0241] The 3-formyl coumarin compound of formula (I) of the present invention can be used as a photoinitiator in UV-VIS LED light source curing systems, especially in light source curing systems with radiation wavelengths of 300-550 nm, particularly 365-475 nm.
[0242] The 3-formylcarbamate coumarin compound of formula (I) of the present invention can be used as a pyrolysis photoinitiator in UV-VIS LED light source curing systems, especially in light source curing systems with radiation wavelengths of 300-550 nm, particularly 365-475 nm.
[0243] The 3-formyl coumarin compound of (I) of the present invention can also be used as a hydrogen-abstracting photoinitiator in UV-VIS LED light source curing systems, especially in light source curing systems with radiation wavelengths of 300-550 nm, particularly 365-475 nm.
[0244] According to the present invention, the 3-formyl coumarin compound of formula (I) can be used in combination with a compound selected from tertiary amine compounds (such as ethyl 4-dimethylaminobenzoate, i.e., EDB), α-amino acid compounds, or thiols. According to the present invention, these compounds act as hydrogen donors, and the 3-formyl coumarin compound here acts as a hydrogen-abstracting photoinitiator in conjunction with the hydrogen donor such as EDB to initiate a free radical polymerization reaction.
[0245] One aspect of the present invention provides the use of the 3-formyl coumarin compound of formula (I) as a photoinitiator-sensitized onium salt, particularly in UV-VIS LED light source curing systems, especially in light source curing systems with radiation wavelengths of 300-550 nm, particularly 365-475 nm. In this aspect, the 3-formyl coumarin compound of formula (I) may also be referred to as a photosensitizer.
[0246] The onium salt may be selected from iodonium salts and thionium salts.
[0247] The iodonium salts and thionium salts respectively have the following general formulas (A) and (B).
[0248]
[0249] in
[0250] R a R b R c R d R e Each is an unreplaced C6-C. 10aryl, or selected from halogen, nitro, carbonyl, C1-C 12 Alkyl, C1-C 12 Alkoxy, phenylthio, phenyl, and substituted phenyl groups at C6-C 10 The aryl group, preferably phenyl or naphthyl, or a phenyl or naphthyl group substituted with a substituent selected from halogens, nitro groups, C1-C6 alkyl groups, and substituted phenyl groups, wherein the substituted phenyl group comprises one or more substituents selected from halogens, nitro groups, C1-C6 alkyl groups, and C1-C6 alkoxy groups; and
[0251] Y and Z are non-nucleophilic anions, such as trifluoromethanesulfonate and BF4. - ClO4 - PF6 - AsF6 - SbF6 - .
[0252] Preferably, the thioonium salt is selected from one or more of the following groups: mixed thioonium hexafluorophosphate (GR-SS058), 4-(phenylthio)phenyl·diphenylthioonium hexafluorophosphate, 4-(phenylthio)phenyl·diphenylthioonium hexafluoroantimonate (GRSS059), diphenyl-(4-phenylthio)phenylthioonium hexafluoroantimonate (GRSS059B), and mixed thioonium hexafluoroantimonate (GR-SS061).
[0253] Preferably, the iodonium salt is selected from one or more of the following group: diphenyl iodonium hexafluorophosphate (810), 4-isobutylphenyl-4'-tolyl iodonium hexafluorophosphate (GR-IS051), bis(4-dodecylbenzene)iodonium hexafluoroantimonate (GR-IS052), bis(4-dodecylbenzene)iodonium hexafluorophosphate (GR-IS052B), (4-octyloxyphenyl)benzene iodonium hexafluoroantimonate (GR-IS053), bis(4-tert-butylbenzene)iodonium hexafluorophosphate (GR-IS054), bis(4-tert-butylbenzene)iodonium hexafluoroantimonate (GR-IS225), 4,4'-xylyl iodonium hexafluorophosphate, and 4,4'-xylyl iodonium hexafluoroantimonate.
[0254] In one embodiment, the iodonium salt is a diaryliodonium salt, preferably a diphenyliodonium salt. The thiodonium salt is a triarylthiodonium salt, preferably a triphenylthiodonium salt.
[0255] The onium salt sensitized by the 3-formyl coumarin compound of formula (I) can be used to initiate free radical photopolymerization, or to initiate cationic photopolymerization, or to initiate free radical-cationic hybrid photopolymerization.
[0256] Photoinitiator composition
[0257] The present invention also relates to a photoinitiator composition comprising a 3-formyl coumarin compound of formula (I) of the present invention.
[0258] In one embodiment, the composition comprises a 3-formyl coumarin compound of formula (I) and a compound selected from tertiary amine compounds, α-amino acid compounds, or thiols. As described above, these compounds act as hydrogen donors. The weight ratio of the 3-formyl coumarin compound of formula (I) to the compound selected from tertiary amine compounds, α-amino acid compounds, or thiols can be 10:1 to 1:10 (e.g., 8:1, 5:1, 2:1, 1:1, 1:2, 1:5, 1:8), preferably 5:1 to 1:5, more preferably 2:1 to 1:2.
[0259] In one embodiment, the composition comprises a 3-formyl coumarin compound of formula (I) with an onium salt. The onium salt may be selected from iodonium salts and thiodonium salts, particularly iodonium salts and thiodonium salts as described above.
[0260] The weight ratio of the 3-formyl ester coumarin compound of formula (I) to the onium salt can be 10:1 to 1:100 (e.g., 8:1, 5:1, 2:1, 1:1, 1:2, 1:5, 1:10, 1:20, 1:30, 1:40, 1:50, 1:80), preferably 5:1 to 1:80, more preferably 1:1 to 1:50 or 1:2 to 1:50.
[0261] The 3-formyl coumarin of formula (I) of the present invention can be used as a photoinitiator in UV-VIS LED photocuring technology. The 3-formyl coumarin compound of formula (I) of the present invention can also be used as a photoinitiator in coatings, inks, microelectronics, printing, and other fields. When the 3-formyl coumarin compound of formula (I) of the present invention is used as a photoinitiator, its dosage is as described below for photocurable compositions.
[0262] Photocurable composition
[0263] The present invention also relates to photocurable compositions comprising at least one 3-formyl coumarin compound of formula (I) of the present invention or a photoinitiator composition of the present invention.
[0264] In the photocurable composition, the amount of the 3-formyl ester coumarin compound of formula (I) of the present invention or the photoinitiator composition of the present invention is generally 0.001-10% by weight (e.g., 0.005% by weight, 0.01% by weight, 0.05% by weight, 0.1% by weight, 0.2% by weight, 0.5% by weight, 1% by weight, 2% by weight, 5% by weight or 8% by weight), preferably 0.1-6% by weight, such as 0.2-5% by weight, based on the amount of active ingredient in the photocurable composition.
[0265] In the context of this disclosure, active ingredient refers to the component in a photocurable composition other than the solvent.
[0266] In addition to the photoinitiator of the present invention, the photocurable composition also comprises a photopolymerizable component, such as a photocurable resin. The photocurable resin may be a free radical photocurable resin and / or a cationic photocurable resin.
[0267] In this invention, the photocurable resin has photocurable reactive groups, such as unsaturated carbon-carbon double bonds and / or epoxy groups. For example, the photocurable resin can be an oligomer or prepolymer containing unsaturated carbon-carbon double bonds and / or epoxy groups. Upon exposure to light, this oligomer or prepolymer can undergo a polymerization reaction initiated by a photoinitiator, leading to cross-linking and curing. The photocurable resin is a major component of photocurable products (e.g., UV coatings, UV inks, UV adhesives, etc.).
[0268] As photocurable resins (free radical photocurable resins) containing unsaturated carbon-carbon double bonds, examples include epoxy (meth)acrylate resins, polyester (meth)acrylates, polyether (meth)acrylates, polyurethane (meth)acrylates, olefinically unsaturated polyesters, amino (meth)acrylate resins, and photo-imaging alkali-soluble resins. According to the present invention, it is advantageous to use epoxy (meth)acrylate resins, polyester (meth)acrylates, polyether (meth)acrylates, polyurethane (meth)acrylates, or combinations thereof.
[0269] The preferred epoxy (meth)acrylate resins are bisphenol A epoxy (meth)acrylate, bisphenol A epoxy acrylate diluted with tripropylene glycol dimethacrylate, or combinations thereof, such as bisphenol A epoxy acrylate WSR-U125 from Wuxi Resin Factory, China; bisphenol A epoxy acrylate 621A-80 diluted with 20% tripropylene glycol diacrylate from Chang Hsing Chemical Co., Ltd., Taiwan; modified bisphenol A epoxy acrylate 623-100 from Chang Hsing Chemical Co., Ltd., Taiwan; and modified bisphenol A epoxy acrylate 6231A-80 diluted with 20% tripropylene glycol diacrylate from Chang Hsing Chemical Co., Ltd., Taiwan.
[0270] The preferred polyester (meth)acrylates are highly functional hyperbranched polyester acrylate resins, especially those with a functionality of 5-30, such as hyperbranched polyester acrylate prepolymers with a functionality of 6-20. Examples include hyperbranched polyester acrylate prepolymers 932-100 (6 functionality) from Wuxi Knox Co., Ltd. in China, and hyperbranched polyester acrylate prepolymers CN2300 (8 functionality), CN2301 (9 functionality), and CN2302 (16 functionality) from Sartoma Co., Ltd. in the United States.
[0271] The polyether (meth)acrylate can be polyethylene oxide (meth)acrylate, polypropylene oxide (meth)acrylate, polyethylene oxide-propylene oxide (meth)acrylate, or a combination thereof. An example is PEG(400) diacrylate.
[0272] Polyurethane (meth)acrylates are preferably aliphatic polyurethane acrylates. Examples include aliphatic polyurethane hexaacrylates 6145-100 and 6161-100 from Chang Hsing Chemical Co., Ltd. (Taiwan), aliphatic polyurethane diacrylate 611B-85 diluted with 15% 1,6-hexanediol diacrylate (HDDA), polyester polyol acrylic resin diluted with 20% ethoxytrimethylolpropane triacrylate, and aliphatic polyurethane diacrylate 6141H-80; aliphatic polyurethane acrylate CN9013 (9 functionalities) from Sartoma Chemical Co., Ltd. (USA), aliphatic polyurethane acrylate CN966B85 (2 functionalities) diluted with 15% 1,6-hexanediol diacrylate (HDDA) from Sartoma Chemical Co., Ltd. (USA), and aliphatic polyurethane acrylate CN962 (2 functionalities).
[0273] The amount of photocurable resin in the photocurable composition is typically 10-90% by weight, preferably 55-80% by weight, based on the amount of active ingredient in the photocurable composition. In the context of this disclosure, active ingredient refers to the component in the photocurable composition other than the solvent.
[0274] The photocurable composition may further include a multifunctional active diluent.
[0275] In this invention, a multifunctional reactive diluent refers to a monomer containing two or more photopolymerizable groups. Multifunctional reactive diluents have low viscosity and strong dissolving power. After being irradiated by a light source, multifunctional reactive diluents can be polymerized by active free radicals to form a cross-linked network structure.
[0276] According to the present invention, the preferred multifunctional reactive diluent is a multifunctional (meth)acrylate reactive diluent. This refers to a monomer containing two or more polymerizable (meth)acrylate groups. Examples of multifunctional (meth)acrylate reactive diluents include trimethylolpropane triacrylate (TMPTA), pentaerythritol tetraacrylate (PETTA), propoxylated trimethylolpropane triacrylate (PO-TMPTA), or ethoxylated trimethylolpropane triacrylate (EO-TMPTA), pentaerythritol triacrylate (PETA), pentaerythritol tetraacrylate (PETTA), dipentaerythritol pentaacrylate (DPEPA), dipentaerythritol hexaacrylate (DPHA), diol diacrylates such as tripropylene glycol diacrylate (TPGDA), 1,6-hexanediol diacrylate (HDDA), triethylene glycol dimethacrylate, diethylene glycol dimethacrylate, glycerol diacrylate, and urethane dimethacrylate (UDMA), etc.
[0277] The amount of the multifunctional active diluent in the photocurable composition is typically 8-60% by weight, preferably 15-45% by weight, based on the amount of active ingredient in the photocurable composition.
[0278] According to the present invention, the photocurable composition may further comprise a monofunctional active diluent.
[0279] In this invention, a monofunctional reactive diluent refers to a monomer containing a photopolymerizable group. It has low viscosity, strong dissolving power, and can act as a partial organic solvent. After being irradiated by a light source, this monofunctional reactive diluent can be polymerized by active free radicals. Monofunctional reactive diluents mainly include (meth)acrylate compounds and vinyl compounds. Examples of (meth)acrylate monofunctional reactive diluents include methyl methacrylate (MMA), n-butyl acrylate (BA), isooctyl acrylate (2-EHA), isodecyl acrylate (IDA), lauryl acrylate (LA), hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, and some (meth)acrylates with cyclic structures. Additionally, examples of vinyl monofunctional reactive diluents include styrene (St), vinyl acetate (VA), and N-vinylpyrrolidone (NVP).
[0280] The amount of monofunctional reactive diluent in a photocurable composition is typically 5-50% by weight, preferably 8-40% by weight, based on the amount of active ingredient in the photocurable composition.
[0281] In one embodiment of the invention, the photocurable composition may be free of reactive diluents, such as polyfunctional reactive diluents and monofunctional reactive diluents.
[0282] The photocurable composition of the present invention may optionally contain an organic solvent. The choice of organic solvent is conventional. Examples of organic solvents include aromatic hydrocarbons such as benzene and toluene, halogenated alkanes such as chloroform, dichloromethane, and chloroethane, ketones such as acetone, butanone, and pentanone, alcohols such as methanol, ethanol, propanol, isopropanol, and ethylene glycol, and ethylene glycol ethers, ethylene glycol ether acetates, propylene glycol ethers, and propylene glycol ether acetates. In one embodiment, the photocurable composition may be solvent-free.
[0283] The photocurable composition of the present invention may optionally include other additives, such as leveling agents, antioxidants, antisettling agents, colorants, microbial agents, such as antibacterial agents, and thermal insulation material additives. In a preferred embodiment of the invention, the leveling agent is selected from Yoka Chemicals. FLOW series leveling agents, with 360S, 372S, 384S, 392S, 400U, and 415U being particularly preferred.
[0284] The preparation of the photocurable composition of the present invention is conventional; for example, each component of the photocurable composition of the present invention can be uniformly mixed together.
[0285] Furthermore, the present invention relates to a photocurable composition based on a cationic photopolymerization mechanism comprising a 3-formyl coumarin compound of formula (I) of the present invention. In addition to the 3-formyl coumarin compound of the present invention, the photocurable composition of the present invention also comprises an onium salt co-initiator and a photocurable resin (cationic photocurable resin). The onium salt can be referred to the specific description above.
[0286] In this invention, onium salt co-initiators can generate conjugated acids under the sensitization of 3-formyl ester coumarin compounds, initiating cationic photopolymerization reactions of alkenyl ether compounds, ethylene oxide compounds, and oxetane compounds. The alkenyl ether compounds, ethylene oxide compounds, and oxetane compounds can be in monomer or resin form (including oligomers or prepolymers).
[0287] As a photocurable resin (cationic photocurable resin), it can include alkenyl ether compounds, oligomers or prepolymers containing ethylene oxide, propylene oxide, or oxetane functional groups. When exposed to light, this oligomer or prepolymer can undergo a polymerization reaction initiated by a photoinitiator, leading to cross-linking and curing. Photocurable resins are the main component of photocurable products (such as UV coatings, UV inks, UV adhesives, etc.).
[0288] In this invention, the alkenyl ether compound can be a C1-C6 alkenyl ether compound, such as vinyl ethers, 1-propenyl ethers, 1-butenyl ethers, 1-pentenyl ether compounds, etc., preferably vinyl ether compounds. The alkenyl ether compound is, for example, an alkenyl ether starting from a monohydric alcohol having 1-12, preferably 1-6 carbon atoms, a dihydric alcohol having 2-12, preferably 2-8 carbon atoms, a trihydric alcohol or more having 3-12, preferably 3-6 carbon atoms, particularly a C1-C6 alkenyl ether. Polymers containing alkenyl ether functional groups, such as vinyl ethers, may also be mentioned as alkenyl ether compounds. Specific examples may include one or more of the following: triethylene glycol divinyl ether, isobutyl vinyl ether, methyl vinyl ether, ethyl vinyl ether, propyl vinyl ether, isopropyl vinyl ether, butyl vinyl ether (BVE), hydroxyethyl vinyl ether, diethylene glycol divinyl ether (DEGDVE), triethylene glycol divinyl ether (TEGDVE), vinyl n-octyl ether, divinyl-1,4-butanediol ether, 2-ethylhexyl vinyl ether, 1,4-cyclohexyldiethanol divinyl ether, 4-hydroxybutyl vinyl ether (HBVE), triethylene glycol divinyl ether (DVE-3), glycerol carbonate vinyl ether, and dodecyl vinyl ether. Furthermore, compounds having both vinyl ether and (meth)acrylate alkyl ester structures may also be mentioned, and these compounds may be used simultaneously with one or more of them. The alkenyl compounds also include carbamates containing one or more, such as 1-3 alkenyl ether structures. The carbamates containing alkenyl ether structures can be obtained by reacting alkenyl ethers with hydroxyl groups with isocyanate compounds (such as polyisocyanate compounds). Examples include diethyleneoxyalkyl carbamates and trifunctional vinyl ethers prepared from 1,6-hexamethylenediisocyanate trimers and 4-hydroxyvinyl ethers.
[0289] According to the present invention, examples of the oxetane compounds may include 3,3'-(oxybis(methylene)bis(3-ethyl)oxetane, 3-ethyl-3-oxetane methanol, bis[(3-methyl-3-oxetane-butylmethoxy)methyl] ether, bis[(3-ethyl-3-oxetane-butylmethoxy)methyl] ether, 1,4-bis[(3-methyl-3-oxetane-butylmethoxy)methyl]benzene, 1,4-bis[(3-methyl-3-oxetane-butylmethoxy)methyl]benzene, etc. [3-Oxetane-3-oxetane-3-oxetane]benzene, methyl acrylate (3-methyl-3-oxetane), methyl acrylate (3-ethyl-3-oxetane), methyl methacrylate (3-methyl-3-oxetane), methyl methacrylate (3-ethyl-3-oxetane), 3-methyl-3-ethylenehydroxymethyloxetane, 3-methyl-3-ethylenehydroxypolyethoxylated methyloxetane, 1,4-bis(3- Ethyl-3-oxetane(methoxy)butane, 1,6-bis(3-ethyl-3-oxetane(methoxy)hexane, pentaerythritol tris(3-ethyl-3-oxetane(methyl) ether, 3-methyl-3-hydroxymethyloxetane, 3-ethyl-3-hydroxymethyloxetane, 1,3-bis[(3-ethyl-3-oxetane(methoxy)methyl]propane, polyethylene glycol bis(3-ethyl-3-oxetane)butane 3-ethyl-3-oxetane methyl (3-ethyl-3-oxetane methyl) ether, ethylene glycol bis(3-ethyl-3-oxetane methyl) ether, tricyclodecanedimethyldimethylene (3-ethyl-3-oxetane methyl) ether, trimethylolpropane tri(3-ethyl-3-oxetane methyl) ether, pentaerythritol tetra(3-ethyl-3-oxetane methyl) ether, 3-epoxyethylene 7-oxetane [4.1].[0] Heptane, and 3-ethyl-3-oxabutane methanol (GR-OXT-01), 3-ethyl-3-chloromethyloxabutane (GR-OXT-02), 3,3'-(oxybismethylene)bis(3-ethyl)oxabutane GR-OXT-03, 3-ethyl-3-(2-ethylhexyloxymethyl)oxabutane (GR-OXT-04), 3,3'-((((propane-2,2-diylbis(4,1-phenylene))bis(oxy))bis(methylene))bis(3-ethyloxabutane)(GR-OXT-05), 3-ethyl-3-(benzyloxymethyl)oxabutane produced by Gurun Technology. This includes polyfunctional oxetane compounds such as oligomers or copolymers of one or more of the following: oxetane (GR-OXT-06), oxetane methacrylate (GR-OXT-09), and bis[(3-ethyloxetane-3-yl)methyl]benzene-1,4-dicarboxylic acid ester (GR-OXT-11); oxetane alcohols and etherified resins containing hydroxyl groups, such as phenolic varnish resins, poly(p-hydroxystyrene), Cardo-type bisphenols, calixarenes, resorcinol calixarenes, or silsesquioxanes. Compounds possessing both oxetane and alkyl (meth)acrylate structures can also be cited.
[0290] The ethylene oxide compounds may be selected, for example, from glycidyl ether epoxy compounds, glycidyl ester epoxy compounds, glycidyl amine epoxy compounds, aliphatic epoxy compounds, alicyclic epoxy compounds, etc. Ethylene oxide compounds may be in the form of monomers or resins (such as oligomers or prepolymers). Compounds simultaneously having an ethylene oxide group and a free radical polymerizable group (such as an acrylate group) may also be mentioned, such as epoxy (meth)acrylate resins. Glycidyl ether epoxy compounds (especially aliphatic glycidyl ether epoxy compounds, bisphenol A type glycerol ether epoxy compounds) and aliphatic epoxy resins are preferred. Furthermore, compounds simultaneously having an ethylene oxide group (such as an alicyclic ethylene oxide or glycidyl ether group) and a (meth)acrylate alkyl ester structure are preferred.
[0291] Examples of these ethylene oxide compounds include 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexylcarboxylate (6110), bis(3,4-epoxycyclohexylmethyl adipic acid) (UVR-6128), trimethylolpropane glycidyl ether (TPEG), 1,2-epoxy-4-vinylcyclohexane, methyl 3,4-epoxycyclohexane carboxylate, 4,5-epoxycyclohexane-1,2-dicarboxylic acid diglycidyl ester, tetrahydrophthalic acid diglycidyl ester, hexahydrophthalic acid diglycidyl ester, bisphenol A diglycidyl ether (E-03 type), 3-epoxyethylene 7-oxabicyclo[4,1,0]heptane, ethylene glycol diglycidyl ether, C 12 -C14 Alkyl glycidyl ethers, polypropylene glycol diglycidyl ethers, polyethylene glycol diglycidyl ethers, polyether polyol glycidyl ethers, glycidyl methacrylate, trimethyloltriglycidyl ether, 1,4-butanediol diglycidyl ether, and their oligomers or copolymers, as well as polyfunctional epoxy compounds such as EPIKOTE Resin 862, EPIKOTE Resin 827, EPIKOTE Resin 869, EPIKOTE Resin 320, EPIKOTE Resin 816, EPIKOTE Resin 232, EPIKOTE Resin 144, etc. These compounds can be used in one or more forms.
[0292] Furthermore, the present invention relates to a photocurable composition comprising a 3-formyl coumarin compound of formula (I) of the present invention, based on a radical-cationic hybrid photopolymerization mechanism. In addition to the 3-formyl coumarin compound of the present invention, such photocurable compositions also comprise ononium salts and photocurable resins (radical photocurable resin and cationic photocurable resin).
[0293] In this invention, the onium salt is preferably selected from iodonium salts and thiodonium salts, and more preferably from diaryliodonium salts and triarylthiodonium salts. A detailed description of the onium salt is provided above.
[0294] The photocurable resin is a free radical photocurable resin and a cationic photocurable resin. For details on free radical photocurable resins and cationic photocurable resins, please refer to the detailed description above.
[0295] The photocurable composition of the present invention may optionally contain an organic solvent. The choice of organic solvent is conventional. Examples of organic solvents include aromatic hydrocarbons such as benzene and toluene, halogenated alkanes such as chloroform, dichloromethane, and chloroethane, ketones such as acetone, butanone, and pentanone, alcohols such as methanol, ethanol, propanol, isopropanol, and ethylene glycol, as well as ethylene glycol ethers, ethylene glycol ether acetates, propylene glycol ethers, and propylene glycol ether acetates.
[0296] The photocurable composition of the present invention may optionally include other additives, such as leveling agents, antioxidants, antisettling agents, colorants, microbial agents, such as antibacterial agents, and thermal insulation material additives. In a preferred embodiment of the invention, the leveling agent is selected from Yoka Chemicals. FLOW series leveling agents, with 360S, 372S, 384S, 392S, 400U, and 415U being particularly preferred.
[0297] The preparation of the photocurable composition of the present invention is conventional; for example, each component of the photocurable composition of the present invention can be uniformly mixed together.
[0298] Photocurable material and method of preparation
[0299] Another aspect of the present invention provides a curable material obtainable from the photocurable composition of the present invention. The resulting curable material can be a photocurable coating, such as a coating containing functional materials, a coating for UV and / or visible light filters; a sealant; a photolithography material; a holographic recording material; a 3D printing material; a lithographic printing material; a material for fabricating optical devices; and a material for improving mechanical properties, such as carbon fiber composites and / or inorganic nanoparticles and / or organic nanoparticles, etc.
[0300] The present invention also relates to a method for preparing a photocurable material, comprising irradiating the photocurable composition with a light source having a radiation wavelength of 300-550 nm, particularly 365-475 nm, such as a UV-VIS LED light source.
[0301] Furthermore, the compound of formula (I) disclosed in this invention has a simple production process and high yield, making it very suitable for industrial production. This type of compound exhibits good compatibility with UV-VIS LED light sources with radiation wavelengths of 300-550 nm, especially 365-475 nm, and can be widely used as a photoinitiator in fields related to UV-VIS LED photocuring, such as coatings, inks, microelectronics, printing, 3D printing, and dental materials.
[0302] Furthermore, the limited variety of photoinitiators currently available for deep curing of UV-VIS LED light sources, especially long-wavelength UV-VIS LED light sources, restricts the widespread application of UV-VIS LED light sources in the photocuring field. The 3-formyl coumarin compound of formula (I) of this invention can be used for deep curing with UV-VIS LED light sources, thereby contributing to the widespread application of green and environmentally friendly UV-VIS LED light sources in the UV photocuring industry.
[0303] Examples
[0304] The present invention will be explained below with reference to embodiments. Those skilled in the art will understand that the following embodiments are for illustrative purposes only and should not be considered as limiting the scope of the invention. Where specific techniques or conditions are not specified in the embodiments, they shall be performed in accordance with the techniques or conditions described in the literature or product specifications in the art.
[0305] Example 1: Preparation of compound 1
[0306]
[0307] The synthetic route for compound 1 is as follows:
[0308]
[0309] Synthesis of intermediate compound 1a
[0310] 0.05 mol (9.10 g) of 4-methyl-2-hydroxy-5-methylthiobenzaldehyde was added to a 250 mL three-necked round-bottom flask containing 50 mL of ethanol. After stirring until homogeneous, piperidine (0.015 mol, 1.28 g) and ethyl acetoacetate (0.07 mol, 9.11 g) were added. The reaction mixture was then heated to reflux and stirred for 4 h. After the reaction was complete, the mixture was cooled to room temperature and filtered to obtain a yellow solid. The solid was then recrystallized from ethanol to give 10.17 g of product, with a yield of 82%, which was identified as compound 1a. ¹H-NMR (400 MHz, CDCl₃) δ 8.45 (s, 1H), 7.50 (s, 1H), 6.98 (s, 1H), 2.46 (s, 3H), 2.37 (s, 3H), 2.34 (s, 3H).
[0311] Synthesis of intermediate compound 1b
[0312] Intermediate compound 1a (9.92 g, 0.04 mol), SeO2 (11.09 g, 0.1 mol), and 70 mL of pyridine were added to a 250 mL three-necked round-bottom flask. The reaction was stirred at 130 °C for 2 h, and the reaction progress was monitored by TLC. The reaction was stopped immediately when impurities were detected. The reaction solution was cooled to room temperature, filtered to remove insoluble matter, and a large amount of ethyl acetate was added to the filtrate, resulting in the precipitation of a solid powder. The filter cake was filtered, and acidified with hydrochloric acid to convert the pyridine salt of coumarin 3-formylcarboxylic acid to the corresponding carboxylic acid. The mixture was stirred at room temperature for 2 h, finally yielding 5.89 g of a yellow solid product, with a yield of 53%, which was identified as compound 1b. 1H-NMR (400MHz, CDCl3) δ12.56(s,1H),8.45(s,1H),7.50(s,1H),6.98(s,1H),2.46(s,3H),2.34(s,3H).
[0313] Synthesis of target compound 1
[0314] Intermediate compound 1b (5.56 g, 0.02 mol), methanol (0.77 g, 0.024 mol), and 100 mL of dichloromethane were added to a 250 mL three-necked round-bottom flask. The reaction was stirred at 40 °C for 2 h, and the reaction progress was monitored by TLC. After the reaction was complete, the organic phase was extracted three times with NaHCO3 and hydrochloric acid aqueous solution, and dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporation under reduced pressure, finally yielding 4.38 g of a yellow solid product, with a yield of 75%, which was identified as compound 1. The NMR data of compound 1 are shown in Table 1.
[0315] Examples 2-17: Preparation of compounds 2-17
[0316] Repeat the method of Example 1, and appropriately change the reaction raw materials to obtain compounds 2-17 in the table below and their NMR data.
[0317] Table 1
[0318]
[0319]
[0320]
[0321] Characterization 1: Ultraviolet-Visible light absorption performance test:
[0322] Taking the compounds of Examples 1-3 as examples, the ultraviolet-visible light absorption properties of the compounds of the present invention were tested. The molar extinction coefficients of the compounds of Examples 1-3 in acetonitrile (50 ppm) were measured and calculated by UV-Vis spectroscopy. Figure 1 Table 2 lists the maximum absorption wavelength (λmax) and the corresponding molar extinction coefficient, as well as the molar extinction coefficient at common LED light source emission wavelengths. Figure 1 As shown in Table 2, the compounds in Examples 1-3 have good absorption in the near-UV-Vis range, which matches the common UV-Vis ultraviolet LED light source in the 300nm-500nm range.
[0323] Table 2 - Maximum absorption wavelengths λ of compounds in Examples 1-3 max And the corresponding molar extinction coefficient, and the molar extinction coefficient at common LED light source emission wavelengths.
[0324]
[0325]
[0326] Characterization 2: Photoinitiation performance test:
[0327] Raw materials used:
[0328] TPGDA: Tripropylene glycol diacrylate (acrylate monomer), purchased from Shanghai Yinchang New Materials Co., Ltd.
[0329] 6110: 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexylcarboxylate (epoxy monomer), purchased from Hubei Gurun Technology Co., Ltd.;
[0330] EDB: Ethyl N,N-dimethylaminobenzoate, purchased from Beijing Innocare Technology Co., Ltd.;
[0331] GR-SS061: Mixed thionium hexafluoroantimonate, composed of diphenyl-(4-phenylthio)phenylsulfonium hexafluoroantimonate and bis(4-(diphenylsulfonium)phenyl)sulfide-bis(hexafluoroantimonate) (thionium salt, abbreviated as GR61), purchased from Hubei Gurun Technology Co., Ltd.
[0332] Test method:
[0333] Fourier transform infrared (FTIR) and Fourier transform infrared-real-time infrared (FTIR) methods were used to test the free radical polymerization of acrylate (TPGDA) initiated by the compounds in the above examples as oil-based photoinitiators, and the cationic polymerization of epoxy monomer (6110) initiated by sensitized thionium salts. The characteristic peaks of the acrylate and epoxy monomers were selected at 1630 cm⁻¹, respectively. -1 (carbon-carbon double bond) and 916 cm -1 (Epoxy functional group). The photoinitiator's photoinitiation performance under different conditions was evaluated based on the trend of conversion rate change over time under different test conditions.
[0334] Preparation of photocurable compositions:
[0335] (1) Prepare a free radical polymerizable photocurable composition 1 containing the compound of Example 3 as a photoinitiator according to the following composition:
[0336] 100 parts by weight of TPGDA acrylate monomer
[0337] 1 part by weight of the compound (photoinitiator) in Example 3
[0338] (2) Prepare photocurable compositions 2-18, each containing the compounds of Examples 1-17 as photoinitiators, according to the following composition:
[0339] 100 parts by weight of TPGDA acrylate monomer
[0340] 1 part by weight of the compounds (photoinitiators) in Examples 1-17
[0341] EDB 1.16 parts by weight
[0342] (3) Cationic polymerizable photocurable compositions 19, 20 and 21, each containing the compounds of Examples 1-3, were formulated according to the following compositions:
[0343] 100 parts by weight of 6110 epoxy monomer
[0344] 0.2 parts by weight of compounds from Examples 1-3
[0345] GR-SS061 4 parts by weight
[0346] (4) Prepare photocurable comparative composition 1, which does not contain the compounds of the present invention, according to the following composition:
[0347] Epoxy monomer 6110 100 parts by weight
[0348] Onion salt GR-SS061 4 parts by weight
[0349] Photoinitiation performance testing
[0350] After the above compositions are stirred and mixed evenly under yellow light, the photocurable compositions are injected into a pre-treated KBr double salt sheet mold that meets the following conditions using a syringe:
[0351] KBr double salt plate size: 15mm × 15mm
[0352] KBr double salt plate thickness: 3mm
[0353] KBr double salt plate gap: 0.5mm
[0354] By observing the syringe scale, the amount of photocurable composition injected into the KBr double salt plate mold was 0.2 ml. After injection, the KBr double salt plate mold was placed in the small black box of the Fourier transform infrared spectrometer used for real-time infrared testing. The structure of the small black box was such that the infrared test light above was vertically aligned and penetrated the KBr double salt plate mold, and the 45° LED point light source above the KBr double salt plate mold was aligned with the KBr double salt plate mold. The distance between the LED point light source and the KBr double salt plate mold was 1 cm.
[0355] Simultaneously, infrared spectroscopy detection and LED light source are activated, allowing the photocurable composition in the KBr double salt plate mold to be exposed while detecting changes in the area of characteristic peaks.
[0356] Under the illumination of an LED point light source, photopolymerizable compounds undergo polymerization in the presence of an initiator, resulting in the formation of carbon-carbon double bonds (1630 cm⁻¹). -1 ) or epoxy functional group (916cm) -1 The area of the characteristic peak continuously decreases until it almost disappears. Based on the data on the change of the characteristic peak area with exposure time, the conversion rate of the monomer over time is calculated.
[0357] Based on the data on the change of characteristic peak area of carbon-carbon double bonds or epoxy functional groups with exposure time, the formula for the conversion rate of monomers with time is obtained:
[0358]
[0359] The kinetic curves of the double bond conversion rate of monomer TPGDA in photocurable composition 1 using the compound of Example 3 as a function of time were tested under light sources of 415 nm, 450 nm, and 475 nm.Figure 2 a) Data shows that TPGDA monomers exhibit high conversion efficiency and conversion rate under all three light sources, with the following conversion rates at 30 s: 415nm: 58.9%; 450nm: 72.9%; 470nm: 56.7%. At 415nm, 50mW / cm²... 2 The kinetic curves of the double bond conversion rate of monomer TPGDA in photocurable compositions 2, 3, and 4, which contain compounds from Examples 1-3, EDB, and monomer TPGDA, as a function of time were tested under a light source. Figure 2 b). For example Figure 2 As shown in b, under a 415 nm light source, the compounds of Examples 1-3 can rapidly initiate TPGDA monomers and have a high double bond conversion rate. The conversion rates at 30 s are as follows: Compound 1 + EDB: 76.0%; Compound 2 + EDB: 60.6%; Compound 3 + EDB: 74.8%.
[0360] At 415nm, 100mW / cm 2 Under a light source, photocurable compositions 19, 20, and 21 containing compounds of Examples 1, 2, or 3, thioonium salt GR-SS061, and epoxy monomer 6110, as well as a comparative photocurable composition 1 containing only thioonium salt GR-SS061 and epoxy monomer (6110), were tested to show the conversion rate versus exposure time. Figure 3 c), wherein the conversion rates at 100 s were: Compound 1 + GR-SS061: 49.3%; Compound 2 + GR-SS061: 67.3%; Compound 3 + GR-SS061: 30.6%; GR-SS061 only: 0. The data show that the two-component system of the compound of this invention / GR-SS061 (0.2% / 4% w / w) can effectively initiate the ring-opening polymerization of epoxy monomer 6110 under a 415 nm LED light source. Figure 3 c). Under the same conditions, the conversion curve of comparative composition 1, which does not contain the compounds of the present invention, shows that the polymerization rate of epoxy monomer 6110 is very low when GR-SS061 is used alone. This result demonstrates that the compounds of the present invention can effectively sensitize thioonium salts to achieve efficient cationic photocuring.
[0361] The photocurable compositions 2-18 were used to test the polymerization of oil-soluble acrylate monomer TPGDA initiated by compounding the compounds of Examples 1-17 with EDB under LED light sources at 365nm, 385nm, 400nm, 415nm, 425nm, 450nm, and 475nm, with an exposure time of 5 min (light intensity: 100mW / cm²). 2 The final double bond conversion rate (%) of TPGDA at that time is shown in Table 3.
[0362] Table 3
[0363]
[0364]
[0365] Characterization 3: Photoinitiation performance tested using the PhotoDSC method
[0366] Raw materials used:
[0367] 6110: 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexylcarboxylate (epoxy monomer), purchased from Hubei Gurun Technology Co., Ltd.;
[0368] GR-IS054: Bis(4-tert-butylphenyl)iodonium hexafluorophosphate (iodonium salt, abbreviated as GR54), purchased from Hubei Gurun Technology Co., Ltd.;
[0369] Test method:
[0370] The photoinitiation performance of the above-described compounds as photoinitiators for the cationic polymerization of epoxy monomer (6110) sensitized by iodine salts was tested using PhotoDSC (METTLER TOLEDO DSC 1 / 1100SF). The photoinitiation performance of the photoinitiator under different conditions was evaluated based on the trend of conversion rate over time under different test conditions.
[0371] Specifically, the photoinitiation properties of the compound were tested according to the following steps.
[0372] Preparation of photocurable compositions:
[0373] (1) Cationicly polymerizable photocurable compositions 22, 23 and 24, each containing the compounds of Examples 1-3, were formulated according to the following compositions:
[0374] 100 parts by weight of 6110 epoxy monomer
[0375] 0.2 parts by weight of compounds from Examples 1-3
[0376] GR54 4 parts by weight
[0377] (2) Prepare a cationic polymerizable photocurable comparative composition 2 containing no compounds of the present invention according to the following composition:
[0378] 100 parts by weight of 6110 epoxy monomer
[0379] GR54 4 parts by weight
[0380] Photoinitiation performance testing
[0381] After thoroughly mixing the above-mentioned curable composition under yellow light, approximately 5 mg of the photocurable composition was transferred into a pre-prepared aluminum crucible using a capillary tube. The crucible containing the sample was then transferred to a temperature sensor platform using tweezers, and tested under a nitrogen atmosphere at an isothermal temperature of 40°C. The power of the irradiation source was adjusted to ensure a light intensity of 100 mW / cm² when reaching the sample. 2 After starting PhotoDSC detection for 30 seconds, the LED light source was turned on. After the test was completed, the area of the exothermic peak was integrated, and the conversion rate of the epoxy functional groups was determined according to equation (1):
[0382]
[0383] Where ΔH t Let t be the heat of reaction released at time t, and ΔH0 be the theoretical heat of complete monomer conversion (ΔH0 = 96.7 kJ / mol for epoxy monomer 6110).
[0384] Under 385, 415, 450, and 475 nm LED light sources, the relationship curves of reaction heat (heat flux) versus exposure time and conversion rate versus exposure time per unit mass of composition 23 containing the compound of Example 2 per unit time are shown below. Figure 3 a. The conversion rates at 100 s were: 385 nm: 31.5%; 415 nm: 29.3%; 450 nm: 22.4%; 475 nm: 13.3%. Data shows that the two-component system of the compound from Example 2, combined with iodonium salt GR54 (0.2% / 4% w / w), can initiate the ring-opening polymerization of epoxy monomer 6110 with good efficiency under LED light sources at 385, 415, 450, and 475 nm, with 385 nm showing the best efficiency. Therefore, at 385 nm and 100 mW / cm², the conversion rate is... 2 Compositions 22 and 24, each containing compounds of Examples 1 or 3, and comparative composition 2, containing only GR54, were tested. The curves showing the relationship between heat flux and exposure time, and the curves showing the relationship between conversion rate and exposure time are shown below. Figure 3 b, where the conversion rates at 100 s were: Compound 1 + GR54: 33.0%; Compound 3 + GR54: 21.21%; GR54 only: 0.1%. The results show that the compound / GR54 two-component system of Examples 1-3 can effectively initiate the ring-opening polymerization of epoxy monomer 6110 under a 385 nm LED light source. Under the same conditions, the conversion rate results of Comparative Composition 2, which does not contain the compounds of the present invention, indicate that the polymerization rate of epoxy monomer 6110 is very low when GR54 is used alone. This result demonstrates that the compounds of the present invention can effectively sensitize iodonium salts to achieve efficient cationic photocuring.
[0385] Characterization 4: Deep curing performance test
[0386] The compounds from Examples 1 and 2 were used as photoinitiators to initiate the curing of acrylate monomers (TPGDA), demonstrating the ability to achieve deep curing. The curing depth of the acrylate monomers after 5 minutes of exposure is shown in [Figure Number]. Figure 4 The photoinitiator's photoinitiation performance under different conditions was evaluated based on the trend of curing depth changes under different test conditions.
[0387] Specifically, the photoinitiation properties of the compound were tested according to the following steps.
[0388] (1) Photocurable compositions 25 and 26, each containing the compound of Example 1 or 2, were prepared according to the following composition:
[0389] 100 parts by weight of TPGDA acrylate monomer
[0390] 0.01 parts by weight of the compound from Example 1 or 2
[0391] After the above compositions were stirred and dissolved evenly under yellow light, the light-cured compositions were injected into a glass tube with an inner diameter of 1 cm and a length of 10 cm using a syringe, and then wrapped with aluminum foil. A light intensity of 100 mW / cm² was used. 2 A 415nm LED light source was used to irradiate the bottom of the test tube. After irradiation, the curing depth of the samples was measured. The experimental results showed that compounds of Examples 1 and 2 at a mass concentration of 0.01% (parts per ten thousand) could initiate polymerization to a depth of more than 9 cm within 5 minutes of exposure. Specifically, the curing depths of photocurable compositions 25 and 26 were 9.4 cm and 9.6 cm, respectively (see [references]). Figure 4 (a) and 4(b)). It can be seen that the compounds of the present invention have excellent deep curing properties.
Claims
1. Use of 3-formyl coumarin compounds of formula (I) as photoinitiators: in: R1 is H, a straight-chain or branched C1-C8 alkyl or C1-C8 alkoxy group; R2 is H, a straight-chain or branched C1-C8 alkyl, C2-C6 alkynyl, diC2-C4 alkylamino, or C1-C8 alkoxy; wherein the C2-C6 alkynyl is replaced by a diC1-C4 alkylamino group. 10 Aryl substitution; R3 is H, nitro, straight-chain or branched C1-C8 alkyl or C1-C8 alkoxy; R4 is H; R5 is H; and R6 is a straight-chain or branched C1-C6 alkyl group; or R1 and R2, R2 and R3, or R3 and R4 together with the carbon atoms they are bonded to form a 6-membered aromatic carbon ring fused with the benzene ring in the coumarin structure. or R1, R2, and R3, or R2, R3, and R4 together with the carbon atoms they are bonded to, form a dihydroisoquinoline dione structure or structure of formula (a) fused with the benzene ring in the coumarin structure: (a) in Indicates the position where the coumarin structure is fused with the benzene ring; and The dihydroisoquinolinedione structure and the structure shown in formula (a) are either not substituted or the dihydroisoquinolinedione structure contains one or more C1-C6 alkyl groups as substituents. Where at least one of R1, R2, R3, and R4 is not H and R5 is H. The 3-formyl coumarin compound of formula (I) is used as a photoinitiator for sensitizing onium salts in a light source curing system with a radiation wavelength of 450-475 nm.
2. The use according to claim 1, wherein the cyclic nitrogen atom on the dihydroisoquinolinedione structure is replaced by a C1-C6 alkyl group.
3. The use according to claim 1, wherein 2 or 3 of R1, R2, R3 and R4 are H and R5 is H.
4. The use according to claim 1 or 2, wherein the 3-formylcarbamate coumarin compound of formula (I) is selected from the group consisting of: 。 5. The use according to claim 1, wherein the 3-formyl coumarin compound of formula (I) is used in combination with a compound selected from tertiary amine compounds, α-amino acid compounds or thiols.
6. The use according to claim 1, wherein the onium salt is selected from iodonium salts and thionium salts.
7. The use according to claim 1, wherein the onium salt is selected from diaryliodoonium salts and triarylthionium salts.
Citation Information
Patent Citations
1-carbalkoxy-2H-isoindazole derivative, preparation method and intermediate thereof
CN101875627A
Polycyclic glyoxylates as photoinitiators
CN109790137A
Hormone releasing hormone receptor antagonists and uses thereof
CN113527213A
Coumarin glyoxylate for LED photocuring
CN114829348A
